Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 1/2009

01-01-2009 | Brief Report

Risk factor analysis of invasive liver abscess caused by the K1 serotype Klebsiella pneumoniae

Authors: J.-K. Kim, D. R. Chung, S. H. Wie, J. H. Yoo, S. W. Park, the Korean Study Group for Liver Abscess

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 1/2009

Login to get access

Abstract

The increasing prevalence of Klebsiella pneumoniae liver abscess in Asian countries is attributable to virulent strains of the K1 serotype. We investigated the risk factors for the K1 serotype K. pneumoniae liver abscess. A case-control study was performed using the database of a nationwide study of liver abscess in Korea. Multivariate logistic regression analysis was performed for 78 cases of the K1 serotype K. pneumoniae liver abscess and 81 controls with non-Klebsiella. Diabetes mellitus was the significant risk factor (OR 2.13; 95% CI 1.026 ~ 4.428; P = 0.042) for the K1 serotype K. pneumoniae liver abscess. Biliary disorders had a strong negative association (OR 0.18; 95% CI 0.078 ~ 0.410; P < 0.001). This study suggests that diabetes mellitus is a more significant risk factor for the K1 serotype K. pneumoniae liver abscess than for the non-Klebsiella liver abscess.
Literature
1.
go back to reference Wang JH, Liu YC, Lee SS, Yen MY, Chen YS, Wann SR et al (1998) Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis 26:1434–1438PubMedCrossRef Wang JH, Liu YC, Lee SS, Yen MY, Chen YS, Wann SR et al (1998) Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis 26:1434–1438PubMedCrossRef
2.
go back to reference Chung DR, Lee SS, Lee HR, Kim HB, Choi HJ, Eom JS et al (2007) Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea. J Infect 54:578–583PubMedCrossRef Chung DR, Lee SS, Lee HR, Kim HB, Choi HJ, Eom JS et al (2007) Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea. J Infect 54:578–583PubMedCrossRef
3.
go back to reference Ko WC, Paterson DL, Sagnimeni AJ, Hansen DS, von Gottberg A, Mohapatra S et al (2002) Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis 8:160–166PubMedCrossRef Ko WC, Paterson DL, Sagnimeni AJ, Hansen DS, von Gottberg A, Mohapatra S et al (2002) Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis 8:160–166PubMedCrossRef
4.
go back to reference Fung CP, Chang FY, Lee SC, Hu BS, Kuo BI, Liu CY et al (2002) A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut 50:420–424PubMedCrossRef Fung CP, Chang FY, Lee SC, Hu BS, Kuo BI, Liu CY et al (2002) A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut 50:420–424PubMedCrossRef
5.
go back to reference Cryz SJ Jr, Mortimer PM, Mansfield V, Germanier R (1986) Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development. J Clin Microbiol 23:687–690PubMed Cryz SJ Jr, Mortimer PM, Mansfield V, Germanier R (1986) Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development. J Clin Microbiol 23:687–690PubMed
6.
go back to reference Holt JM, Spry CJ (1966) Solitary pyogenic liver abscess in patients with diabetes mellitus. Lancet 2:198–200PubMedCrossRef Holt JM, Spry CJ (1966) Solitary pyogenic liver abscess in patients with diabetes mellitus. Lancet 2:198–200PubMedCrossRef
7.
go back to reference Ayvazian LF (1948) Friedlander bacillus meningitis successfully treated with streptomycin: consideration of Friedlander bacillus infections in diabetes. Am J Med 5:470–477PubMedCrossRef Ayvazian LF (1948) Friedlander bacillus meningitis successfully treated with streptomycin: consideration of Friedlander bacillus infections in diabetes. Am J Med 5:470–477PubMedCrossRef
8.
go back to reference Thomsen RW, Jepsen P, Sorensen HT (2007) Diabetes mellitus and pyogenic liver abscess: risk and prognosis. Clin Infect Dis 44:1194–1201PubMedCrossRef Thomsen RW, Jepsen P, Sorensen HT (2007) Diabetes mellitus and pyogenic liver abscess: risk and prognosis. Clin Infect Dis 44:1194–1201PubMedCrossRef
9.
go back to reference Lin JC, Siu LK, Fung CP, Tsou HH, Wang JJ, Chen CT et al (2006) Impaired phagocytosis of capsular serotypes K1 or K2 Klebsiella pneumoniae in type 2 diabetes mellitus patients with poor glycemic control. J Clin Endocrinol Metab 91:3084–3087PubMedCrossRef Lin JC, Siu LK, Fung CP, Tsou HH, Wang JJ, Chen CT et al (2006) Impaired phagocytosis of capsular serotypes K1 or K2 Klebsiella pneumoniae in type 2 diabetes mellitus patients with poor glycemic control. J Clin Endocrinol Metab 91:3084–3087PubMedCrossRef
10.
go back to reference Fang CT, Lai SY, Yi WC, Hsueh PR, Liu KL, Chang SC (2007) Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clin Infect Dis 45:284–293PubMedCrossRef Fang CT, Lai SY, Yi WC, Hsueh PR, Liu KL, Chang SC (2007) Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clin Infect Dis 45:284–293PubMedCrossRef
Metadata
Title
Risk factor analysis of invasive liver abscess caused by the K1 serotype Klebsiella pneumoniae
Authors
J.-K. Kim
D. R. Chung
S. H. Wie
J. H. Yoo
S. W. Park
the Korean Study Group for Liver Abscess
Publication date
01-01-2009
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 1/2009
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-008-0595-2

Other articles of this Issue 1/2009

European Journal of Clinical Microbiology & Infectious Diseases 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.